Rexin-G Dose 2

GENETIC2 trials

Sponsors

Epeius Biotechnologies

Conditions

OsteosarcomaPancreatic Cancer

Phase 1

Evaluation of Safety of Rexin-G Gene Transfer for Advanced Pancreatic Cancer

TerminatedNCT00121745

Epeius BiotechnologiesPancreatic Cancer

Start: 2005-07-31End: 2007-07-31Updated: 2007-12-20

Phase 2

Phase II Study of Intravenous Rexin-G in Osteosarcoma

CompletedNCT00572130

Epeius BiotechnologiesOsteosarcoma

Start: 2007-12-31End: 2011-06-30Updated: 2011-06-10